Intramuscular Sotrovimab Well Tolerated, Noninferior To Intravenous Administration In Patients With COVID-19, Research Suggests

Infectious Disease Advisor (8/15, Chan) reports that study results suggest “that the intramuscular administration of sotrovimab for the treatment of COVID-19 infection is well tolerated and noninferior to intravenous administration.” The findings of the r...